Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.
Estrogen Mediates Neuroprotection and Anti-Inflammatory Effects during EAE through ERα Signaling on Astrocytes But Not through ERβ Signaling on Astrocytes or Neurons.
Restless legs syndrome as the initial presentation of multiple sclerosis.
Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases.
Aquaporin-4 antibody negative recurrent isolated optic neuritis: Clinical evidence for disease heterogeneity.
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.
[Future challenges in multiple sclerosis].
Stoppers and non-starters of disease-modifying treatment in multiple sclerosis.
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.
The evolutionarily conserved Tre2/Bub2/Cdc16 (TBC), Lysin motif (LysM), Domain catalytic (TLDc) domain is neuroprotective against oxidative stress.
Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
White and gray matter damage in primary progressive MS: The chicken or the egg?
Effect of Inhaled Interferon Beta-1a on Carbon Monoxide Transfer Factor in Healthy Volunteers.
The triggering receptor expressed on myeloid cells 2 - a molecular link of neuroinflammation and neurodegenerative diseases.
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.
Monoclonal antibodies as disease modifying therapy in multiple sclerosis.
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?
Venous endothelial injury in central nervous system diseases.
Does long-term partial sodium channel blockade alter disease progression in MS? Evidence from a retrospective study.
The MoSt Project--More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.
Evaluation of Focal Cervical Spinal Cord Lesions in Multiple Sclerosis: Comparison of White Matter-Suppressed T1 Inversion Recovery Sequence versus Conventional STIR and Proton Density-Weighted Turbo Spin-Echo Sequences.
Underrecognition of Sleep Disorders in Patients with Multiple Sclerosis.
Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.

Pages